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2Abstract
The immediate tissue microenvironment of implanted biomedical devices and engineered
tissues is highly influential on their long term fate and efficacy. The creation of a long-term anti-
inflammatory microenvironment around implants and artificial tissues can facilitate their integration.
Macrophages are highly plastic cells that define the tissue reactions on the implanted material. Local
control of macrophage phenotype by long-term fixation of their healing activities and suppression of
inflammatory reactions are required to improve implant acceptance. Herein, we describe the
development of a cytokine cocktail (M2Ct) that induces stable M2-like macrophage phenotype with
significantly decreased pro-inflammatory cytokine and increased anti-inflammatory cytokine secretion
profile. The positive effect of the M2Ct was shown in an in vitro wound healing model; where M2Ct
facilitated wound closure by human fibroblasts in co-culture conditions. Using a model for induction of
inflammation by LPS we have shown that the M2Ct phenotype is stable for 12 days. However, in the
absence of M2Ct in the medium macrophages underwent rapid pro-inflammatory re-programming upon
IFNg stimulation. Therefore, loading and release of the cytokine cocktail from a self-standing,
transferable Gelatin/Tyraminated Hyaluronic acid based release system was developed to stabilize
macrophage phenotype for in vivo application in implantation and tissue engineering. The M2Ct
cytokine cocktail retained its anti-inflammatory activity in controlled release conditions. Our data
indicate that the direct application of a potent M2 inducing cytokine cocktail in a transferable release
system can significantly improve the long term functionality of biomedical devices by decreasing pro-
inflammatory cytokine secretion and increasing the rate of wound healing.
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31. Introduction
Responsive biomedical devices and tissue engineered structures have been becoming
increasingly common for the treatment of organ/tissue loss or damage. However, lack of control over
the host response to implanted systems significantly affects the clinical outcomes [1]. For example,
McConnell et al reported that in an animal model the presence of intracortical electrodes led to chronic
inflammation with subsequent dendritic cell and neuron loss [2]. The innate immune response is the
first reaction of the host tissue against implanted materials where macrophages play an important role.
Macrophages are phenotypically plastic immune cells which have a wide array of responses as a
consequence of biophysical and biochemical stimuli in immediate vicinity; they are particularly
responsive to the pro- or anti-inflammatory cytokines which determine their phenotype as pro-
inflammatory or pro-healing [3].
The presence and accumulation of macrophages during wound healing at the wound site is an
important step in the process that leads to wound closure. This has been confirmed by selective ablation
of macrophages in transgenic mice by application of diphtheria toxin, which resulted in impaired
extracellular matrix (ECM) secretion, lower levels of epithelialization and angiogenesis [4]. Moreover,
it has been recently reported that the presence of macrophages is beneficial for facilitation of engineered
tissue vascularization [5]. Thus, engineering a microenvironment around implanted devices or artificial
tissues that would convert macrophages to a more pro-healing phenotype (generally designated as M2)
is a promising approach to improve the integration of the device and attenuate the adverse immune
reactions [6, 7]. Furthermore, phenotype-controlled macrophages polarized by anti-inflammatory
cytokines have previously been used to treat chronic inflammatory conditions and favored implant
tolerance in mouse models [1, 8, 9].
In vitro induction of macrophage phenotype has been regularly achieved by the use of specific
cytokines/stimulants such as interferon-gamma (IFNg), interleukin-4 (IL4), bacterial
lipopolysaccharides (LPS) etc. [10]. The resulting macrophage phenotypes can be categorized into the
conventional M1-M2 classification, or as subgroups of M1 and M2 (such as M2a). However, there is a
trend in the immunology field to describe macrophage phenotypes with respect to the actual stimulation
4[11]. Furthermore, the physiological signaling conditions are not as clear as one cytokine/one phenotype
equivalency and several cytokines can act simultaneously. This has led us to hypothesize that a designed
cytokine cocktail might be more potent in establishing and more importantly fixing a desired cytokine
phenotype than a single cytokine induction. Recently, human monocyte-derived macrophages with
dominant anti-inflammatory phenotype were generated using cytokine cocktail consisting of M-CSF (50
ng/ml), IL4 (20 ng/ml), IL10 (20 ng/ml) and TGFβ1 (20 ng/ml) in RPMI 1640 medium supplemented 
with 10% fetal bovine serum (FBS) [12].
In order to exert a long term control over the implanted material microenvironment, the
establishment of controlled release of desired cytokines is necessary. This can be achieved by methods
such as incorporation of nanoparticles or nanocapsules within the implanted device; however, diffusion
of the particles itself might hinder the local control [13]. Adhesive, self-standing thin films are attractive
delivery systems in this aspect, as they can be applied to the surfaces of implants and engineered tissues
and also have the capacity to be loaded and then release cytokines and growth factors in a time dependent
manner. We have recently shown the efficacy of immunomodulatory thin films on controlling the
behavior of primary human macrophages [14, 15]. However, these films needed to be formed in-situ
and could not be transferred. For ensuring wide scale applicability transferable release platforms are
desirable.
In this study, we have optimized a cytokine cocktail that ensures high level of M2-like
conversion of naive primary human monocytes with long term phenotypic stability in the presence of
cocktail components. In order to show the indirect positive effects of such conversion in healing of
connective tissue; a wound healing assay was done in the presence of phenotype controlled macrophages
with human fibroblasts. Finally, for controlled release of the cytokine cocktail around implantable
devices, a transferable release system based on gelatin and tyramine derivative of hyaluronic acid was
designed and tested in the presence of primary macrophages.
2. Materials and Methods
2.1 Isolation of human monocyte-derived macrophages, cell stimulations and culture conditions
5Monocytes were isolated from buffy coats of healthy donors as described previously [16-18].
Briefly, cells were purified by density gradients followed by positive magnetic selection using CD14+
MACS beads (Miltenyi Biotech, Bergisch Gladbach, Germany). Monocytes were cultured at 1 × 106
cell/ml in serum free macrophage-SFM medium (ThermoFisher Scientific) supplemented with 10 ng/ml
M-CSF (Peprotech) and 10-8M dexamethasone (dex) (Sigma-Aldrich, Munich, Germany) for the time
periods indicated in the relevant sections. Cells were additionally stimulated with human IFNg (100
ng/ml), IL4 (10 ng/ml) or combination of IL4+IL10+TGFβ1 with concentrations of individual cytokines 
indicated in the relevant sections. All cytokines were from Peprotech. LPS (Invivogen) was added in
concentration 1 µg/ml for 24h at the time-points indicated in the relevant sections. For long term analysis
of phenotype monocytes were cultured for 12 days without changing the medium and addition of new
cytokines. To assess macrophage phenotype changes after cytokine deprivation monocytes were
cultured in complete medium with cytokines. On day 6 of culture medium was replaced either by
complete medium with freshly added cytokines or basal medium containing 1 ng/ml M-CSF and 10-8M
dex and macrophages were cultured for 6 more days.
2.2 Wound healing assay
For wound healing assay, human lung fibroblasts (MRC-5) were routinely cultured as described
[19] and 5 x 104 cells/well were seeded in a 12-well plate (Corning) for 5 days to reach 80% confluence.
Concurrently monocytes were differentiated into macrophages for 6 days in the presence of 50 ng/ml
M-CSF (Miltenyi Biotech) in ultra-low attachment plates (Corning). Naive macrophages were polarized
in the presence of the following cytokine mixtures: 20 ng/ml IFNg + 50 ng/ml GM-CSF (M1-like); 3
ng/ml IL4 + 10 ng/ml M-CSF (M2-like) and 10 ng/ml M-CSF + 3 ng/ml IL4 + 10 ng/ml IL10 + 10
ng/ml TGFβ1 (M2Ct) in SFM medium for 48h. Different cytokine-polarized macrophages (1.5 x105
/well) were co-cultured with fibroblasts in 12 well plates immediately after inflicting a wound using
micropipette tip. In order to follow wound closure, MRC5 were pre-labelled with 25 µM of CFDA-SE
(Invitrogen) according to manufacturer’s instructions. Fluorescence images were taken using a DMIRE2
Fluorescence Microscope (Leica) with a 2.5x objective. Fluorescence intensity of wound area was
6quantified using Image J software and data was expressed in percentage of wound closure at 24h and
48h relative to the area of the wound at time point zero.
2.3 Production and characterization of self-standing thin film based controlled release system
Gelatin type B (Mw =2-2.5×104 Da, pI = 4.7-5.2) from bovine skin and fluorescein
isothiocyanate labeled Bovine Serum Albumin (BSAFITC, Mw = 6.6 × 104 Da, pI = 4.7–4.9) were
purchased from Sigma Aldrich (St. Quentin Fallavier, France). Microbial Transglutaminase (M-TG)
(Mw =3.8×104 Da, pI = 9) was obtained from Ajinomoto (Japan). HA-Tyramine (HA-Tyr, Mw = 3,1 x105
Da) were produced and characterized by Contipro (Czech Republic).
Gelatin/HA-tyramine films were prepared by spin coating with a protocol described before [20].
Briefly, the films were prepared with a solution of gelatin (14% w/v) mixed with HA-tyramine (1% w/v)
in 0.15 M NaCl/10 mM Tris solutions (pH = 7.4). Then 200µL of this solution at 50°C were put on a
glass slide (previously installed on the spin coater). The spin coating was done with a rotation speed of
2500 rpm and an acceleration of 1250 rpm for 2 minutes. These films can be double crosslinked through
two different processes in order to get an interpenetrated network (IPN) : i) gelatin was crosslinked with
transglutaminase (TGA) to get amide bond between amine groups on lysine residues and carboxamide
groups (RCONH2) on glutamine residues, 10% of TGA in PBS (w/v) were incubated on gelatin/HA-
tyramine film; and ii) HA-tyramine crosslinking based on dimerization of tyramine to dityramine by
horseradish peroxidase mediated reaction, a solution of H2O2:HRP (10:1) was prepared with 0.24mg/mL
of HRP in PBS and 0.1M H2O2 and incubated on top of each film.. These films were crosslinked with
100µL of TGA and then with 100µL of HRP solution for 30 minutes for each step. The films were
washed 3 times with PBS after each step.
The films were characterized by scanning electron microscopy (SEM) and confocal microscopy.
SEM micrograph images were taken by an XL SIRION FEG (FEI Company Eindhoven) with an
acceleration voltage of 30 kV. Before imaging, the samples were freeze dried after being frozen in liquid
nitrogen. Confocal laser scanning microscopy images were obtained with a Zeiss LSM 710 microscope
using a ×20 objective in order to get thickness estimation and 3D reconstructions. The films were stained
with a solution of 1 mg/mL of fluorescently labeled BSAFITC. FITC fluorescence was detected after
7excitation at λ = 488 nm and an emission band-pass filter of 489-556nm. All the experiments were 
performed in PBS solution. The BSA loading was studied in situ and in real-time using the XNano II
nanoplasmonic sensing instrument (Insplorer®, Insplorion, Sweden).
2.4 Effect of controlled release on macrophage phenotype
To generate controlled cytokine release system adhesive coatings were incubated with cytokines
in SFM medium for 24h at +4°C. All cytokines were applied in concentrated amounts (10X) compared
to standard concentrations mentioned above. Shortly before plating monocytes cytokine containing
medium was removed and coatings were washed once with 1 ml SFM medium. Monocytes were
cultured on coatings for 6 days in SFM medium supplemented with 1% penicillin/streptomycin followed
by stimulation with 1 µg/ml LPS for 24h. In parallel, monocytes were cultured on the same type of
coatings in the absence of controlled release system. In this case, cytokines were added in the culture
medium after monocyte seeding. As a control, monocytes were cultured for 6 days without coatings.
2.5 Metabolic activity/viability assay
Cell viability was determined using AlamarBlue Cell Viability Reagent (ThermoFisher
Scientific) according to manufacturer instructions on day 7 of culture. Briefly, AlamarBlue reagent was
diluted 1:10 directly in macrophage culture medium and cells were incubated for 3h, 37°C. Fluorescence
was measured in triplicates at 590 nm. Fluorescence of pure AlamarBlue was used as a negative control.
2.6 Light microscopy
Light microscopy photos of macrophages cultured on adhesive coatings for 6 days were taken
using Axiovert 100 microscope (Zeiss) equipped with 10X objective and AxioVision 4.8.1 software
(Zeiss).
2.7 ELISA
The concentrations of TNF-α, IL1β, IL6, IL1Ra, and CCL18 were measured in macrophage cell 
culture supernatants using human DuoSet ELISA kits (R&D Systems) according to manufacturer
8instructions. Concentration of MMP-7 in supernatants was measured by human Total MMP-7
Quantikine ELISA Kit (R&D systems).
2.8 Statistical analysis
The difference between stimulations was analyzed in GraphPad Prism 6 software using repeated
measures one-way ANOVA with Tukey’s multiple comparisons or Friedman test with Dunn’s multiple
comparisons as indicated. Wound healing data were analyzed using Student’s t test. The difference was
considered significant at p<0.05 level.
3. Results
3.1 M2Ct exerts pronounced anti-inflammatory polarization of macrophages
Macrophages are innate immune cells with remarkable phenotypical plasticity. Depending on
existing cytokine milieu these cells may induce acute inflammation and tissue injury or conversely
resolve inflammation and mediate wound healing. To generate a cytokine cocktail suitable for
application on adhesive coatings, we polarized macrophages towards anti-inflammatory state based on
the combination of M-CSF, IL4, IL10 and TGFβ1 with certain modifications. First, isolated monocytes 
were cultured in serum free medium (SFM) to achieve pure effect of polarizing cytokines and avoid
additional impact of growth factors that can be present in FBS. In addition, we have supplemented
culture medium with corticosteroid dexamethasone in concentration 10-8M to mimic naturally present
glucocorticoids in human blood. In an optimization experiment using macrophages of 4 healthy donors
the combination of IL4+IL10+TGFβ1 showed pronounced synergistic effect on the suppression of TNF-
α production by LPS-stimulated macrophages compared to other cytokine combinations. For instance, 
average TNF-α levels (pg/ml±SD) were 3112,7±2718,4 for IL4 alone, 3679,7±1993,8 for IL4+TGFβ1, 
362,8±213 for IL4+IL10, and 218,4±51 for IL4+IL10+TGFβ1. The combination of IL10+TGFβ1 
resulted in low macrophage viability and was excluded from cytokine production analysis (data not
shown).
 As shown on Fig.1A, B cytokine cocktail consisting of IL4, IL10 and TGFβ1 (M2Ct) strongly 
inhibited production of pro-inflammatory cytokines TNF-α and IL6 in LPS-treated macrophages. 
9Importantly, secretion of these cytokines in M2Ct-treated macrophages was significantly lower
compared to prototypic M2 stimulation with IL4 (Fig.1A, B). We have also decreased concentration of
IL4 from 20 ng/ml to 3 ng/ml that further reduced production of TNF-α in response to pro-inflammatory 
stimulation with LPS (Supplementary Figure 1). At the same time M2Ct enhanced production of M2-
associated chemokine CCL18 and anti-inflammatory cytokine IL1Ra in a similar way as IL4 (Fig.1C,
D).
To study whether M2Ct induces prolonged anti-inflammatory macrophage phenotype we
cultured macrophages for 12 days in the presence of IFNg, IL4, M2Ct, or without stimulation followed
by LPS challenge and TNF-α detection. During this period, culture medium was not changed and fresh 
cytokines were not added. As shown on Fig.2A stimulation with M2Ct resulted in the lowest levels of
TNF-α production compared to other stimulations that was evident for up to 12 days of culture. There 
was highly significant difference between M2Ct and IL4 stimulations on days 6 and 9 of culture. This
trend was also retained on day 12 (Fig. 2A). Since macrophages are phenotypically plastic cells and
promptly revert their phenotype upon changes in cytokine milieu, we have examined whether
withdrawal of M2Ct components from the medium will restore macrophage responsiveness to LPS back
to the level of non-stimulated cells. For this, macrophages were cultured for 6 days followed by
replacement of cytokine-containing complete medium for basal medium deprived of cytokines. After 3
and 6 days of culture in basal medium cells were further challenged with LPS and assessed for TNF-α 
production. Withdrawal of M2Ct components from culture medium for 3 and 6 days resulted in slight
elevation of TNF-α secretion upon LPS challenge without reaching statistical significance (Fig. 2B, 
comparison M2Ct complete vs M2Ct basal). Moreover, even after 6 days of culture in basal medium
M2Ct pre-polarized macrophages retained significantly lower levels of TNF-α compared to non-
stimulated cells which indicated temporary fixation of anti-inflammatory phenotype (Fig. 2B,
comparison ns basal vs M2Ct basal). In contrast, stimulation with IL4 alone was not sufficient to
maintain low levels of TNF-α secretion in basal medium (Fig. 2B, comparison ns basal vs IL4 basal). 
Next, we have assessed whether M2Ct-induced phenotype will be challenged by combination of pro-
inflammatory factors IFNg and LPS that can be simultaneously present in case of bacterial infection.
When M2Ct pre-differentiated macrophages were deprived of M2Ct-containing medium and re-
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stimulated with IFNg followed by additional LPS challenge, they rapidly (in 1 day) restored TNF-α 
production that was comparable to ns and IL4-stimulated macrophages (Fig. 2C). Remarkably, average
increase in TNF-α production after IFNg re-stimulation and LPS challenge was 48.8 times in case of 
M2Ct pre-differentiated macrophages (p<0.05) and 3.4 times for IL4 macrophages (p<0.05), whereas
changes in TNF-α production by non-stimulated macrophages did not reach significance (p=0.197) 
(Supplementary Figure 2). These results suggested that controlled release system will be required in
order to provide prolonged local availability of M2ct components and maintain anti-inflammatory
milieu at the implant surface.
3.2 The fibroblast wound healing induced by M2Ct-polarized macrophages correlates with an
increase in matrix metalloproteinase-7 (MMP-7)
Adequate wound healing response is an important event upon biomaterials implantation. In
order to study the effect of phenotype controlled macrophages on wound healing properties, fibroblast
wound closure was studied by co-culturing with diverse cytokine-polarized monocyte-derived
macrophages after inflicting a wound. Our results clearly show that co-culture with differentially
polarized macrophages resulted in faster wound closure rate compared to single fibroblast culture (Fig.
3A and Fig. 3B). Among all, the fastest wound healing was seen during co-culture with M2Ct- polarized
macrophages, which was more obvious in 24h compared to 48h time-point. Fluorescence quantification
revealed that, M2Ct mediated approximately 25% faster wound closure rates compared to other types
of macrophages (Fig. 3B). In addition to wound closure rate, co-culture with M2Ct polarized
macrophages exhibited complete healing of wound edges compared to co-culture with M2 polarized
macrophage indicating the ability of M2Ct polarized macrophages in regaining normal tissue
architecture. In order to associate improved wound healing mediated by M2Ct with the expression of
pro-healing factors such as MMP7, we measured MMP-7 levels in macrophage/fibroblasts co-cultures.
Interestingly, MMP-7 was only detected in co-culture with macrophages and the highest MMP-7 level
was observed in co-culture with M2Ct polarized cells, which was 3 times higher compared to other co-
culture conditions (Fig. 3C). It is therefore reasonable to suggest that different levels of MMP-7
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produced from the differentially polarized macrophages were at least partly responsible for the observed
differences in the rate of wound healing in different conditions.
3.3 Development and characterization of a self-standing release systems for delivery of M2Ct
Previously, we have reported the controlled release of growth factors from enzymatically
crosslinked gelatin based thin films. As hyaluronan is known to interact with many interleukins we have
incorporated a hyaluronic acid derivative to the film formulation in order to retain more interleukin
components of the cocktail and also to improve the stability of the film by creating an interpenetrating
network of separately crosslinked gelatin and hyaluronic acid (Fig. 4A). SEM analysis and 3D confocal
images of this material have shown a homogeneous and smooth surface (Fig. 4B, D). The average
thickness of this film was evaluated to be approximately 20 µm as shown by confocal images both in
2D (Fig. 4E) and 3D (Fig. 4D). The structure is stable in hydrated form and can be loaded with bioactive
molecules. In order to show the ability of the film to absorb proteins, loading of bovine Serum albumin
(BSA) was monitored with nanoplasmonic sensing (Insplorion, Sweden) (Fig. 4C). By 4h a significant
amount of BSA was absorbed into the film layer, consistent with the confocal microscopy observations.
In order to obtain a transferable delivery system, we introduced a sacrificial layer to the production
protocol which resulted in self-standing membranes. The films could be easily detached from the
substrate by depositing a layer of cellulose acetate on top of the glass slide before the spin coating
process. The spin coating was then performed, but once the film is crosslinked, the interaction between
the film and the glass slide is so weak that it detached easily once immersed in water as shown in Fig.
4F. This process enabled the transfer of the cytokine cocktail loaded films to target environments.
3.4 Controlled release of M2Ct by adhesive coatings favors anti-inflammatory macrophage state
Due to pronounced anti-inflammatory activity and prolonged effect of M2Ct, this cytokine
formulation was selected as an optimal choice for combination with adhesive coatings designed to
support controlled cytokine release. First, controlled release system was generated by pre-incubating
adhesive coatings with components of M2Ct or M-CSF+Dex only (non-stimulated control) for 24h
followed by removal of unbound cytokines and addition of monocytes. In parallel, monocytes were
cultured on coatings in the presence of cytokines without controlled release system (cytokines were
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added in culture medium). As a control, monocytes were cultured without coatings. After 6 days of
culture macrophages were assessed for viability/metabolic activity. The presence of coatings with or
without controlled cytokine release was not toxic and did not affect macrophage viability compared to
control (Supplementary Figure 3). Furthermore, macrophages cultured on coatings had typical
macrophage morphology (Supplementary Figure 4). The assessment of pro-inflammatory cytokine
production upon LPS challenge revealed that coatings alone dramatically inhibited production of TNF-
α by macrophages and this effect was observed in all groups with and without controlled release (Fig. 
5A). As depicted on Fig. 5B and 5C coatings did not significantly influence the production of IL6 and
IL1β by macrophages. Controlled release of M-CSF and dexamethasone (group “ns, controlled release”) 
resulted in elevated production of both IL6 and IL1β, which was counteracted by the presence of M2Ct 
although this effect did not reach statistical significance due to variability in cytokine production
between individual donors (Fig. 5B and 5C). As shown on Fig. 5D the highest production of anti-
inflammatory cytokine IL1Ra was detected in macrophages differentiated in the presence of controlled
release of M2Ct. The concentration of IL1Ra (mean±SD in ng/ml) in M2Ct controlled release group
was 257.8±68.4 vs 146.8±42.1 in non-stimulated controlled release group, and increased IL1Ra
production was observed in all donors (Fig. 5D). This effect did not reach significance due to individual
variations in cytokine production between donors. However, ratio IL1Ra/IL1β was dramatically 
increased in the presence of controlled release of M2Ct compared to non-stimulated cells (Fig. 5E). This
result indicated that M2Ct favored anti-inflammatory phenotype of macrophages cultured on adhesive
coatings. In addition, production of M2-associated chemokine CCL18 was negligible in non-stimulated
macrophages cultured without coatings (Fig. 5F). However, substantial levels of CCL18 were detected
in non-stimulated controlled release group, and were further elevated in M2Ct controlled release group
although this effect did not reach significance (Fig. 5F). Overall, controlled release of M2Ct resulted in
decreased production of pro-inflammatory cytokines TNF-α, IL6, and IL1β and increase of IL1Ra/IL1β 
ratio compared to non-stimulated cells cultured in the presence of controlled release system.
4. Discussion
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In this study we have shown the availability of potent cytokine combination consisting of IL4,
IL10 and TGFβ1 for long-term anti-inflammatory modulation of macrophage phenotype around 
implants. This cytokine cocktail also favored wound healing in vitro and could be combined with self-
standing release systems for prolonged local control of macrophage phenotype.
Controlled release systems are perspective tools for long-term local immunomodulation around
implants that aim to prevent unwanted pro-inflammatory activation of macrophages and stimulate
wound healing [1]. For this purpose, anti-inflammatory cytokines and their combinations can be loaded
on thin adhesive coatings. For example, local immunomodulation using well recognized anti-
inflammatory factor IL4 alleviated biomaterial-induced osteolysis in mice [21]. Controlled release of
IL4 from polyelectrolyte multilayer-based coatings and silk biomaterials was shown to promote
differentiation of macrophages with anti-inflammatory M2 properties [16, 22]. However, IL4 alone may
not be sufficient to sustain long-term anti-inflammatory macrophage phenotype and low responsiveness
to inflammatory stimuli. In our study, production of pro-inflammatory cytokine IL6 upon LPS challenge
was comparable in non-stimulated and IL4-stimulated macrophages. In addition, there was no
significant difference in TNF-α production in response to LPS between non-stimulated and IL4 pre-
differentiated macrophages on day 3 after cytokine withdrawal from culture medium. These data are
supported by the fact that transfer of IL4 differentiated macrophages was not sufficient to protect mice
from lethal endotoxemia [23]. Thus, we have hypothesized that a cytokine cocktail containing
combination of anti-inflammatory factors will be more potent in terms of macrophage phenotype
fixation and long-term phenotype control. The use of multiple factors for macrophage polarization is
also physiologically relevant since the cells in in vivo conditions are always influenced by complex
cytokine milieu. Double and triple combinations of anti-inflammatory factors IL4, IL10 and TGFβ1 
were previously shown to be more efficient than single cytokines, and induced robust tolerogenic
phenotype in mouse and human macrophages [8, 9, 12]. In addition, macrophages stimulated by such
cytokine combinations partially retained anti-inflammatory phenotype in vivo and their adoptive transfer
protected mice from chronic inflammatory disorders including autoimmune type 1 diabetes and
adriamycin nephrosis [8, 9]. In our study, we have utilized triple combination of IL4, IL10 and TGFβ1 
(named M2Ct) in order to generate macrophages with prolonged anti-inflammatory phenotype. We have
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further optimized concentrations of individual cytokines to diminish pro-inflammatory cytokine
production by macrophages and used serum free medium to exclude impact of undefined growth factors
on macrophage phenotype. In these conditions M2Ct cocktail was superior to IL4 in terms of anti-
inflammatory potential and induced long-term inhibition of TNF-α production that was pronounced for 
12 days after single cytokine stimulation. Importantly, macrophages differentiated in the presence of
M2Ct retained their anti-inflammatory properties for 6 days after cytokine withdrawal indicating partial
fixation of phenotype and formation of innate immune memory.
Adequate wound healing response is an important event upon biomaterials implantation which
facilitates tissue integration of implanted biomedical devices [24, 25]. M2-like polarized macrophages
are known to favor healing events following injury [26, 27]. In our study, M2Ct-differentiated
macrophages markedly enhanced fibroblast-mediated wound closure in vitro indicating favorable pro-
healing phenotype that is necessary for successful implant integration in vivo. Improved wound healing
in the presence of M2Ct-differentiated macrophages was associated with elevated production of MMP-
7. These results suggested the role of MMP-7 in wound closure in our system. Previous studies revealed
complex role of MMP-7 in wound healing. For example, elevated presence of MMP-7 in the tissue and
plasma was associated with impaired wound healing in patients with periodontitis and combat wounds
[22, 23]. At the same time MMPs are necessary for matrix remodeling and cell migration during wound
closure [28]. MMP-7 was shown to be involved in re-epithelization after injury and facilitated cell
migration through matrix degradation. MMP-7 deficient mice showed strong impairment in wound
healing [29]. These studies indicated that balanced and timely production of MMPs is required for
efficient healing. Our results revealed that elevated production of MMP-7 in the context of prevailing
anti-inflammatory cytokine milieu generated by M2Ct macrophages is associated with enhanced
fibroblast-mediated wound closure. In addition, these results indicate that M2Ct macrophages not only
acquire an M2-like cytokine secretion profile but they are also capable of controlling other cell types
involved in wound healing such as fibroblasts.
Macrophages are innate immune cells with extreme phenotypic plasticity due to involvement in
both induction and resolution of inflammation. Due to this dual function, permanent fixation of
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macrophage phenotype cannot be achieved. Although M2Ct in our study mediated long-term anti-
inflammatory polarization of macrophages, its withdrawal from culture medium with simultaneous
addition of IFNg completely restored TNF-α production by macrophages upon LPS challenge indicating 
capability of M2-like polarized macrophages for adequate response to exogenous danger stimuli in
dominating pro-inflammatory environment [17]. This result also indicated that the presence of M2Ct is
necessary for the support of anti-inflammatory macrophage phenotype and its prolonged local
availability can be provided by self-standing controlled release systems. The system based on
tyraminated gelatin/hyaluronic acid (HA) was designed with the purpose to retain loaded cytokines and
could be transferred to target environment owing to incorporation of sacrificial layer. Gelatin and
hyaluronic acid have been selected as constituents of adhesive films due to the cytokine and growth
factor retaining capacities of ECM components. HA as a highly swollen, viscous ECM component that
directly affects the distribution and release of growth factors/cytokines via molecular exclusion and
resistance to flow [30]. Utilization of a double enzyme mediated crosslinking process resulted in an
interpenetrating network that was stable in culture conditions up to 21 days. In comparison, our previous
gelatin based system can only survive in culture conditions for 7 days [20]. The loading efficacy of
cytokines on adhesive coatings was previously assessed by us using capillary electrophoresis-tandem
mass spectrometry analysis and was estimated as 10% [20]. This was the basis for the selection of 10X
concentrated amounts of all cytokines for loading in the current study. Interestingly, Gelatin/HA coating
alone induced M2-like macrophage phenotype which was characterized by dramatic decrease in TNF-α 
production in response to LPS as well as moderate increase in IL1Ra, CCL18 and IL1Ra/IL1β ratio. 
This anti-inflammatory effect of the coating could be explained by the presence of HA that is known to
reduce macrophage activation and alleviate inflammation [31, 32]. Anti-inflammatory cytokine IL1Ra
is known to neutralize pro-inflammatory effects of IL1β by binding non-productively to IL1 receptor on 
target cells [33, 34]. Thus, measurement of IL1Ra concentration and IL1Ra/IL1β ratio provides 
important information about pro- and anti-inflammatory properties of biomaterials. Macrophage culture
on Gelatin/HA coatings loaded with M2Ct for 6 days resulted in apparent increase in IL1Ra production
and IL1Ra/IL1β ratio indicating favorable effects of released M2Ct components on M2-like macrophage 
polarization and providing proof for functionality of controlled release system. Another advantage of
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multicomponent release systems is the ability to differentially regulate the release of cytokines which
can provide more biomimetic gradients and an additional control over macrophage polarization beyond
cytokine concentrations.
5. Conclusions
Control of macrophage phenotype around implanted biomaterials can provide a pro-healing
microenvironment that can facilitate the integration of biomaterials and prolong their functional lifetime.
Here we reported a potent cytokine cocktail that can significantly increase the differentiation of
monocytes to M2 macrophages with long term stability. The cocktail increases anti-inflammatory
cytokine production and considerably decreases the pro-inflammatory cytokine release. The functional
effect of the phenotype control was shown in a wound healing model where the presence of M2-like
macrophages obtained via stimulation with the cocktail significantly increased the rate of wound closure.
In order to show the applicability of the cocktail in situ by a controlled release system, a self-standing
gelatin/HA based double crosslinked film was developed and shown to be effective in controlling
macrophage phenotype via delivering the cocktail formulation. Controlled delivery of macrophage
phenotype controlling cytokine cocktails can be used for effective, long term immunomodulation around
implanted materials. Our future research will focus on the further elaboration of the cocktail formula
and determination of the underlying mechanism for phenotype fixation.
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Figure legends:
Figure 1. Anti-inflammatory properties of M2Ct. Monocytes were cultured for 6 days with IFNg,
IL4, M2Ct or left untreated (ns). Concentrations of TNF-α (n=14) (A) and IL6 (n=5) (B) in supernatants
were measured by ELISA after stimulation of the cells with 1 µg/ml LPS for 24h. Concentrations of
CCL18 (n=9) (C) and IL1Ra (n=7) (D) were assessed in supernatants by ELISA before LPS treatment.
*p<0.05, ****p<0.0001, ANOVA with Tukey’s multiple comparisons, nd – no statistical difference.
Figure 2. Macrophage phenotype during long term culture. (A) Monocytes of 7 donors were cultured
for 12 days in the presence of IFNg, IL4, M2Ct or left untreated (ns). On days 6, 9, and 12 of culture
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cells were stimulated with 1 µg/ml LPS for 24h and concentrations of TNF-α in supernatants were 
assessed by ELISA. *p<0.05, ***p<0.001, ANOVA with Tukey’s multiple comparisons. (B)
Monocytes of 5 donors were cultured for 6 days in the presence of IL4, M2Ct or left untreated (ns)
followed by replacement of culture medium for complete medium containing 10 ng/ml M-CSF and
polarizing cytokines or basal medium containing 1 ng/ml M-CSF and 10-8M dexamethasone. On days 3
and 6 after medium change macrophages were stimulated using 1 µg/ml LPS for 24h and concentrations
of TNF-α in supernatants were assessed by ELISA. *p<0.05, Friedman test with Dunn’s multiple 
comparisons. (C) Monocytes of 3 donors were cultured for 6 days in the presence of IL4, M2Ct or left
untreated (ns) followed by removal of conditioned medium and addition of fresh medium containing
IFNg (100 ng/ml) for 24h followed by challenge with LPS (1 µg/ml). TNF-α concentration in 
supernatants was assessed by ELISA. Data are mean ± SD, Nd – no difference, Friedman test with
Dunn’s multiple comparisons.
Figure 3. Wound closure dynamics and MMP-7 levels during fibroblasts co-culture with
differentially polarized macrophages. (A) Human fibroblasts were co-cultured with different
cytokine-polarized macrophages right after inflicting a wound. Fibroblasts were pre-labelled with a
fluorescent cell tracer (25µM CFDA-SE, green fluorescence). Healing was evaluated after 0h, 24h and
48h under a fluorescence microscope with 2.5x objective. Representative images from two independent
experiments are presented. Scale bar = 500µm (B) Quantification of fibroblast wound healing was done
after 24h and 48h co-culture with diverse cytokine-polarized macrophages. Fluorescence intensity of
wound area was quantified using Image J software and data was expressed as a percentage of wound
closure at specific time point. (C) MMP-7 levels were measured in macrophage/fibroblast co-culture
supernatants by ELISA at 24h and 48h after inflicting the wounds, n=2. ***p<0.01 ****p<0.001, Data
are mean ± SEMs, two way ANOVA test.
Figure 4. Characterization of self-standing release system. (A) Schematic illustration of the double
crosslinking process using transglutaminase for gelatin (formation of amide bond between glutamine
and lysine residues) and horseradish peroxidase for HA-tyramine (dimerization of tyramine to
dityramine). (B) SEM picture of the film (cross section). (C) BSA real-time adsorption on gelatin/HA-
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tyramine film using XNano II instrument (Insplorer®). Thickness and homogeneity of the film
determined by confocal microscope either with 2D (E) or 3D (D) pictures using BSAFITC as fluorescent
labelling agent. (F) A representative photograph of the self-standing film.
Figure 5. The effect of adhesive coatings with controlled cytokine release on macrophage
phenotype. Monocytes of 4 donors were cultured for 6 days without coatings (control), and in the
presence of coatings without or with controlled cytokine release. For the cells in control plates and on
coatings without controlled release system cytokines were added in culture medium on day 0.
Concentrations of TNF-α (A), IL6 (B) and IL1β (C) in supernatants were measured by ELISA after
stimulation of the cells with 1 µg/ml LPS for 24h. (D) Concentration of IL1Ra was assessed in
supernatants by ELISA before LPS treatment. (E) IL1Ra/IL1β ratio was calculated by dividing 
concentration of IL1Ra to corresponding concentration of IL1β in the supernatant of the same donor. 
(F) Concentration of CCL18 was assessed in supernatants by ELISA before LPS treatment. Data are
combined for 4 donors and presented as mean ± SD; *p<0.05, **p<0.01, Friedman test with Dunn’s
multiple comparisons.
